These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 27342050)
1. Newcastle disease virus-vectored West Nile fever vaccine is immunogenic in mammals and poultry. Wang J; Yang J; Ge J; Hua R; Liu R; Li X; Wang X; Shao Y; Sun E; Wu D; Qin C; Wen Z; Bu Z Virol J; 2016 Jun; 13():109. PubMed ID: 27342050 [TBL] [Abstract][Full Text] [Related]
2. Recombinant Newcastle disease virus (NDV) expressing Duck Tembusu virus (DTMUV) pre-membrane and envelope proteins protects ducks against DTMUV and NDV challenge. Sun M; Dong J; Li L; Lin Q; Sun J; Liu Z; Shen H; Zhang J; Ren T; Zhang C Vet Microbiol; 2018 May; 218():60-69. PubMed ID: 29685222 [TBL] [Abstract][Full Text] [Related]
3. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse. El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice. Dunn MD; Rossi SL; Carter DM; Vogt MR; Mehlhop E; Diamond MS; Ross TM Virol J; 2010 May; 7():95. PubMed ID: 20462412 [TBL] [Abstract][Full Text] [Related]
5. Protection provided by a recombinant ALVAC(®)-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain. Minke JM; Siger L; Cupillard L; Powers B; Bakonyi T; Boyum S; Nowotny N; Bowen R Vaccine; 2011 Jun; 29(28):4608-12. PubMed ID: 21549780 [TBL] [Abstract][Full Text] [Related]
6. A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII. Schneeweiss A; Chabierski S; Salomo M; Delaroque N; Al-Robaiy S; Grunwald T; Bürki K; Liebert UG; Ulbert S Vaccine; 2011 Aug; 29(37):6352-7. PubMed ID: 21596075 [TBL] [Abstract][Full Text] [Related]
7. Vaccination of mice using the West Nile virus E-protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects mice against a lethal challenge. De Filette M; Soehle S; Ulbert S; Richner J; Diamond MS; Sinigaglia A; Barzon L; Roels S; Lisziewicz J; Lorincz O; Sanders NN PLoS One; 2014; 9(2):e87837. PubMed ID: 24503579 [TBL] [Abstract][Full Text] [Related]
8. Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection. Chu JH; Chiang CC; Ng ML J Immunol; 2007 Mar; 178(5):2699-705. PubMed ID: 17312111 [TBL] [Abstract][Full Text] [Related]
10. Host-range restriction of chimeric yellow fever-West Nile vaccine in fish crows (Corvus ossifragus). Langevin SA; Arroyo J; Monath TP; Komar N Am J Trop Med Hyg; 2003 Jul; 69(1):78-80. PubMed ID: 12932102 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens. Volz A; Lim S; Kaserer M; Lülf A; Marr L; Jany S; Deeg CA; Pijlman GP; Koraka P; Osterhaus AD; Martina BE; Sutter G Vaccine; 2016 Apr; 34(16):1915-26. PubMed ID: 26939903 [TBL] [Abstract][Full Text] [Related]
12. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV). Rosas CT; Tischer BK; Perkins GA; Wagner B; Goodman LB; Osterrieder N Virus Res; 2007 Apr; 125(1):69-78. PubMed ID: 17241683 [TBL] [Abstract][Full Text] [Related]
13. Induction of antigen-specific immune responses in mice by recombinant baculovirus expressing premembrane and envelope proteins of West Nile virus. Zhu B; Ye J; Lu P; Jiang R; Yang X; Fu ZF; Chen H; Cao S Virol J; 2012 Jul; 9():132. PubMed ID: 22799608 [TBL] [Abstract][Full Text] [Related]
14. Oral and parenteral immunization of chickens (Gallus gallus) against West Nile virus with recombinant envelope protein. Fassbinder-Orth CA; Hofmeister EK; Weeks-Levy C; Karasov WH Avian Dis; 2009 Dec; 53(4):502-9. PubMed ID: 20095149 [TBL] [Abstract][Full Text] [Related]
15. A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus. Iglesias MC; Frenkiel MP; Mollier K; Souque P; Despres P; Charneau P J Gene Med; 2006 Mar; 8(3):265-74. PubMed ID: 16308885 [TBL] [Abstract][Full Text] [Related]
16. A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice. Spohn G; Jennings GT; Martina BE; Keller I; Beck M; Pumpens P; Osterhaus AD; Bachmann MF Virol J; 2010 Jul; 7():146. PubMed ID: 20604940 [TBL] [Abstract][Full Text] [Related]
17. A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells. Bonafé N; Rininger JA; Chubet RG; Foellmer HG; Fader S; Anderson JF; Bushmich SL; Anthony K; Ledizet M; Fikrig E; Koski RA; Kaplan P Vaccine; 2009 Jan; 27(2):213-22. PubMed ID: 18996430 [TBL] [Abstract][Full Text] [Related]
18. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis. Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230 [TBL] [Abstract][Full Text] [Related]
19. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies. Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812 [TBL] [Abstract][Full Text] [Related]
20. Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs. Kong D; Wen Z; Su H; Ge J; Chen W; Wang X; Wu C; Yang C; Chen H; Bu Z Virology; 2012 Oct; 432(2):327-35. PubMed ID: 22726244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]